Serial #79332596 Trademark
Serial Number: 79332596 • Registration: 6993894
Serial #79332596 is a trademark filed by
Estetra SRL
on October 28, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
P. Stephen Fardy Swanson, Martin & Bell, LLP
330 N. Wabash Ave.
Suite 3300
Chicago
IL 60611
Trademark Details
Filing Date
October 28, 2021
Registration Date
March 7, 2023
Published for Opposition
December 20, 2022
Filing History
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 28, 2024 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jan 5, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 12, 2023 FICS
FINAL DISPOSITION PROCESSED
Jun 11, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 7, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 7, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Dec 21, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 30, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 30, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2022 TROA
REFUSAL PROCESSED BY IB
Nov 1, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 8, 2022 RFCS
REFUSAL PROCESSED BY MPU
Oct 8, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 10, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 9, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 8, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 3, 2022 REPR
